glp-1 shortage canada news today New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions New project announcement: HHS‑OIG is

Will microdosing still curb appetite

Here's what we believe matters

Novo Nordisks Response to the Lawsuits Novo Nordisks Response to the Lawsuits In the face of mounting legal challenges regarding Ozempic, Novo Nordisk has adopted a multi-faceted approach to address the concerns and defend its product: Official Statements and Public Defense: Novo Nordisk has consistently maintained that patient safety is its highest priority

At Pure Medical Spa, weve seen firsthand how these advanced therapies help patients lose inches, lower inflammation, and improve metabolic healthoften reversing or reducing the risk of obesity-related conditions like type 2 diabetes, high blood pressure, and heart disease